Genome-based Management of Patients in Precision Medicine (Ge-Med) Towards a Genomic Health Program
- Conditions
- Rare DiseasesGenetic Predisposition to Disease
- Registration Number
- NCT04760522
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
The GE-MED APPROACH project will enroll patients (n = appr. 12.000) with unclear molecular cause of the disease, suspected genetic cause of the disease without detailed molecular analysis like Whole Exome Sequencing (WES).
The novelty of this study is to integrate genomic health concepts into immediate clinical care. To achieve these goals, a novel structure for the Triple P (3P) concept of personalized medicine (Personalized, Predictive, Preventive) integrated into a well-established health care system and associated with novel decentralized Disease Analysing Task Forces (DATF) will be implemented.
The overall goal of this study is to implement, for the first time, Whole Genome Sequencing (WGS) analysis as a first line diagnostic test for all clinical indications such as Rare Disease (RD )and familial cancer syndromes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 12000
- Unclear molecular cause of the disease
- Suspected genetic cause of the disease
- Missing informed consent of the patient and if applicable the legal representative
- Previously performed WES or panel analysis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of WGS analysis Day 1 WGS analysis as a first line diagnostic test for all clinical indications
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Hospital Tübingen
🇩🇪Tübingen, Germany